Journals / Tüberküloz ve Toraks / 2015 / Cilt: 63 - Sayı: 3

Zonguldak il merkezinde kronik obstrüktif akciğer hastalığı prevalansı

Prevalence of chronic obstructive pulmonary disease in Zonguldak province of Turkey

Pages
170–177
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: COPD is prevalent and an important public health problem in central Zonguldak province.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Chronic Obstructive Pulmonary Disease (COPD) is increasingly recognized as a leading cause of global morbidity and mortality.
📊
Key Findings & Data:Materials and Methods: Adult population of 71.630 persons living in central Zonguldak were enrolled to the study.
💡
Conclusion & Impact:Conclusion: COPD is prevalent and an important public health problem in central Zonguldak province.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is increasingly recognized as a leading cause of global morbidity and mortality. This study is the first spirometry-based, cross-sectional survey of COPD from Western Black Sea Region of Turkey. In this study we aimed to investigate COPD prevalence in Zonguldak province of Turkey. Materials and Methods: Adult population of 71.630 persons living in central Zonguldak were enrolled to the study. They were selected by random sampling methods based on regional inhabitant listings. 611 adult persons were finally enrolled to the study. They were interviewed face to face, and were given a questionnaire. Spirometry and early reversibility testing were also performed. Results were evaluated according to Global Obstrucive Lung Disease (GOLD) criteria. Results: 42.6% of the study population were males. Mean age was 49.2 ± 15.4. The number of inividuals 40 years and older was 447 (73.1%). COPD prevalence was found as 11.1% in the study population and 14.1% in the population 40 years and older. COPD prevalence in males and females 40 years and older were 19.6% and 9.8% respectively. Mean age of the COPD patients (60.06 ± 13.2 years) was higher than the subjects without COPD (47.8 ± 15.1) (p< 0.001). COPD prevalence was increasing with age categories. COPD severity based on GOLD criteria were as follows: Stage 1 (23.5%), Stage 2 (58.8%), Stage 3 (16.2%) and Stage 4 (1.5%). Prevalence of smoking history was 95.3% in male COPD patients, and 56% in female COPD patients. Smoking was the most common risk factor present in 80.9% of COPD cases, followed by biomass exposure (63.2%), occupational exposure (41.2%) and passive smoking (7.3%). Smoking history and occupational exposure were higher statistically in males than females in both study populatian and COPD cases. Conclusion: COPD is prevalent and an important public health problem in central Zonguldak province.

Özet

Giriş: Günümüzde Kronik Obstrüktif Akciğer Hastalığı (KOAH), tüm dünya ülkelerinde önemli bir sağlık sorunu haline gelmiştir. Diğer hastalıkların mortalite oranlarının yıllar içinde düşmesine karşılık KOAH prevalansı ve mortalitesi giderek artış göstermektedir. Bu çalışma Batı Karadeniz Bölgesinde yapılan ilk spirometrik ve kesitsel KOAH prevelans çalışmasıdır. Bu araştırmada Zonguldak il merkezinde KOAH prevelansını belirlemek amaçlanmıştır. Materyal ve Metod: Zonguldak il merkezinde yaşayan 18 yaş ve üzeri 71.630 kişi çalışmanın hedef popülasyonu olarak kabul edildi. Hedef popülasyondan 611 kişiye, mahalle ve sokak temelinde küme ve sistematik örnekleme yöntemleri birlikte kullanılarak ulaşıldı. Araştırmaya katılan bireylere yüz yüze görüşme yöntemiyle anket formu dolduruldu ve solunum fonksiyon testi ile birlikte erken reversibilite testi yapıldı. Sonuçlar Global Obstrucive Lung Disease (GOLD) kriterlerine göre değerlendirildi. Bulgular: Çalışmaya katılan bireylerin %42.6sı erkek idi. Yaş ortalaması 49.20 ± 15.4 bulundu. Kırk yaş ve üstü birey sayısı 447 (%73.1) idi. KOAH prevalansı çalışma grubunda %11.1, 40 yaş ve üstü bireylerde ise %14.1 olarak saptandı. Kırk yaş ve üstü erkeklerde KOAH prevelansı %19.3, kadınlarda ise %9.8 idi. KOAH saptanan hastaların yaş ortalaması (60.06 ± 13.2) KOAH saptanmayan bireylerin yaş ortalamasından (47.8 ± 15.1) fazlaydı (p< 0.001). Yaş kategorileri arttıkça KOAH prevelansının da arttığı tespit edildi. GOLD spirometrik sınıflandırmasına göre KOAHlı hastaların %23.5i Evre 1de, %58.8i Evre 2de %16.2si Evre 3de ve %1.5i Evre 4te tespit edildi. Sigara içme öyküsü erkek KOAHlı hastaların %95.3ünde, kadın KOAHlı hastaların ise %56sında mevcut idi. KOAHlı hastalarda en sık görülen risk faktörleri sırasıyla sigara (%80.9), biomass maruziyeti (%63.2), mesleksel maruziyet (%41.2) ve pasif sigara içiciliği idi. Sigara ve mesleksel maruziyet hem çalışma grubunda hem de KOAHlı hastalarda erkeklerde daha sık görülmekteydi. Sonuç: KOAH Zonguldak il merkezinde çok belirgindir ve önemli bir halk sağlığı sorunudur.

🔖

Cite This Article

TOR, M., KIRAN, S., ÖRNEK, T., ATALAY, F. (2022). Zonguldak il merkezinde kronik obstrüktif akciğer hastalığı prevalansı. Tüberküloz ve Toraks, Cilt: 63 - Sayı: 3, 170–177. https://ajindex.com/articles/618577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55
  2. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121(Suppl 5):S121-S126
  3. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30:993-1013
  4. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397- 412
  5. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81
  6. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading cause of death in the United States. JAMA 2005;294:1255-9
  7. Muray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997;349:1498-504
  8. Halbert RJ, Isonaka S, George D, Igbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003;123:1684-92
  9. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32
  10. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005;72:471-9
  11. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16
  12. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-60
  13. Kiraz K, Kart L, Demir R, Oymak S, Gulmez I, Unalacak M, et al. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med 2003;26:243-8
  14. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet